Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in Coronary Intermediate Lesion and Type 2 Diabetes
NCT02655757Phase 4Completed
- Start
- Dec 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in atherosclerosis. Started Dec 2015; status: completed.
02
Drugs
sitagliptin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT02655757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655757.